General Erectile Dysfunction
Total Payments
$135,317
Transactions
3
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2021 | $45,041 | 2 | 0 |
| 2019 | $90,276 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $135,317 | 3 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Assessment of the Effect of Length Restriction on Inflatable Penile Implant Rigidity | Boston Scientific Corporation | $90,276 | 0 |
| CUPID | Boston Scientific Corporation | $25,041 | 0 |
| Risk of Major Depressive Disorder in Men with Erectile Dysfunction and Benefits of Inflatable Penile Prosthesis: Analysis of the TriNetX Research Network | Boston Scientific Corporation | $20,000 | 0 |
Top Doctors Receiving Payments for General Erectile Dysfunction
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Seattle, WA | $135,317 | 3 |
Ad
Manufacturing Companies
- Boston Scientific Corporation $135,317
Product Information
- Type Device
- Total Payments $135,317
- Total Doctors 0
- Transactions 3
About General Erectile Dysfunction
General Erectile Dysfunction is a device associated with $135,317 in payments to 0 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is Boston Scientific Corporation.
Payment data is available from 2019 to 2021. In 2021, $45,041 was paid across 2 transactions to 0 doctors.
The most common payment nature for General Erectile Dysfunction is "Unspecified" ($135,317, 100.0% of total).
General Erectile Dysfunction is associated with 3 research studies, including "Assessment of the Effect of Length Restriction on Inflatable Penile Implant Rigidity" ($90,276).